argenx SE's ADAPT SERON trial involves a principal investigator at the University of North Carolina.
1 report, 1 independent
Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
argenx SE's ADAPT SERON trial involves a principal investigator at the University of North Carolina.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
University of North Carolina
public university system for North Carolina, USA
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireargenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG Study met primary endpoint (p-value=0.0068) First global phase 3 study to demonst